Xenetic Biosciences CEO Jeffrey Eisenberg's 2021 pay jumps 68% to $750K
Xenetic Biosciences reports 2021 executive compensation
By ExecPay News
Published: October 17, 2022
Xenetic Biosciences reported fiscal year 2021 executive compensation information on October 17, 2022.
In 2021, three executives at Xenetic Biosciences received on average a compensation package of $593K, a 54% increase compared to previous year.
Average pay of disclosed executives at Xenetic Biosciences
Jeffrey F. Eisenberg, Chief Executive Officer, received $750K in total, which increased by 68% compared to 2020. 49% of Eisenberg's compensation, or $368K, was in salary. Eisenberg also received $119K in non-equity incentive plan, $234K in option awards, as well as $29K in other compensation.
James Parslow, Chief Financial Officer, received a compensation package of $521K, which increased by 45% compared to previous year. 57% of the compensation package, or $299K, was in salary.
Curtis Lockshin, Chief Scientific Officer, earned $508K in 2021, a 46% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on October 17, 2022.